Clinical benefits of inhaled ciclesonide for hospitalized patients with COVID-19 infection: a retrospective study.

ABSTRACT:

Background

The successful management of patients infected with coronavirus disease 2019 (COVID-19) with inhaled ciclesonide has been reported, however few studies have investigated its application among hospitalized patients.

Methods

This retrospective cohort study enrolled all adult patients admitted to our hospital with confirmed COVID-19 infection from May to June 2021. Critical patients who received mechanical ventilation within 24 h after admission and those who started ciclesonide more than 14 days after symptom onset were excluded. The in-hospital mortality rate was compared between those who did and did not receive inhaled ciclesonide.

Results

A total of 269 patients were enrolled, of whom 184 received inhaled ciclesonide and 85 did not. The use of ciclesonide

SUBMITTER: Kuo KC 

PROVIDER: S-EPMC9517967 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature